Details

Karakterizacija in kakovost aluminijevih zlitin za tlačno litje : diplomsko delo
ID Reitmeier, Matjaž (Author), ID Mrvar, Primož (Mentor) More about this mentor... This link opens in a new window

.pdfPDF - Presentation file, Download (1,52 MB)
MD5: 9CF96B800394DED7426B558EF89EC742
PID: 20.500.12556/rul/a7502131-25aa-4ae6-bb58-b162c386a326

Language:Slovenian
Keywords:tlačno litje, aluminijeve zlitine, karakterizacija, kakovost
Work type:High school thesis
Typology:2.11 - Undergraduate Thesis
Organization:NTF - Faculty of Natural Sciences and Engineering
Place of publishing:Ljubljana
Publisher:[M. Reitmeier]
Year:2016
Number of pages:V, 34 f.
PID:20.500.12556/RUL-89035 This link opens in a new window
UDC:621.74
COBISS.SI-ID:1646943 This link opens in a new window
Publication date in RUL:10.02.2017
Views:3521
Downloads:413
Metadata:XML DC-XML DC-RDF
:
REITMEIER, Matjaž, 2016, Karakterizacija in kakovost aluminijevih zlitin za tlačno litje : diplomsko delo [online]. Bachelor’s thesis. Ljubljana : M. Reitmeier. [Accessed 18 April 2025]. Retrieved from: https://repozitorij.uni-lj.si/IzpisGradiva.php?lang=eng&id=89035
Copy citation
Share:Bookmark and Share

Similar documents

Similar works from RUL:
  1. ǂThe ǂimportance of cancer stem cells and epithelial-mesenchymal transition in the progression of non-small cell lung cancer
  2. Gene expression levels of the prolyl hydroxylase domain proteins PHD1 and PHD2 but not PHD3 are decreased in primary tumours and correlate with poor prognosis of patients with surgically resected non-small-cell lung cancer
  3. Study of phosphatidylethanolamine N-methyltransferase gene expression in non-small cell lung cancer tissue
  4. Usefulness of immunohistochemically determined epidermal growth factor receptor mutations in lung cancer
  5. Diabetes mellitus and physical activity
Similar works from other Slovenian collections:
  1. Expression patterns and prognostic relevance of subtype-specific transcription factors in surgically resected small cell lung cancer
  2. Outsourcing predictive biomarker testing in non-small cell carcinoma
  3. Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
  4. Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
  5. NSCLC molecular testing in Central and Eastern European countries

Back